Lex/EU lobbying/European Organisation for Research and Treatment of Cancer
Organisation · Transparency Register · 70539554035-46

European Organisation for Research and Treatment of Cancer

EU lobbying footprint — who they meet, and on what. Built only from official disclosures, every meeting cited.

Disclosed meetings11 (6 EC · 5 EP)
Register no.70539554035-46
Period2025-03-04 → 2026-06-03
In short

European Organisation for Research and Treatment of Cancer has 11 disclosed EU lobbying meetings from 2025-03-04 to 2026-06-03: 6 with the European Commission and 5 with Members of the European Parliament. Source: EU Transparency Register no. 70539554035-46, Commission disclosures and MEP declarations.

Does European Organisation for Research and Treatment of Cancer lobby on the files that affect you?
Run a free exposure scan — see where your company overlaps with this footprint, ranked across the EU corpus.

Lobbying profile

as declared 2025-12-04
Category
Non-governmental organisations, platforms and networks and similar
Legal status
AISBL
Declared lobbying cost
€0
Lobbying FTEs
0.45
Members
1
LobbyFacts / Transparency Register source ↗

Files it’s lobbying on

The org's disclosed policy areas, ranked by number of meetings.

Technology1 mtgs
A disclosed meeting is contact, not influence. Counts are of disclosed meetings only.

Declared fields of interest

Public health · Research and innovation

At a glance

The officials and MEPs most often met, by disclosed-meeting count.

Commission officials
  • Karolina Tomaszewska-Boillot1
  • Sandra Gallina1
  • Patricia Reilly1
  • Kasia Jurczak1
  • Maria Pilar Aguar Fernandez1

Disclosed meetings

Newest first. EC = European Commission, EP = Member of the European Parliament.

  • 2026-06-03EPSOKOL Tomislav
    Health Policysource ↗
  • Intro meetingsource ↗
  • 2026-02-17ECKarolina Tomaszewska-Boillot · Cabinet of Commissioner Olivér Várhelyi
    Clinical trialssource ↗
  • 2026-01-28ECSandra Gallina · Director-General
    EU clinical trials regulationsource ↗
  • 2026-01-27ECPatricia Reilly · Cabinet of President Ursula von der Leyen
    Clinical trialssource ↗
  • 2026-01-22ECKasia Jurczak · Head of Unit
    Introductory meeting with new RTD/D Directorsource ↗
  • 2026-01-22ECMaria Pilar Aguar Fernandez · Director
    Introductory meeting with new RTD/D Directorsource ↗
  • 2025-11-06ECMaya Matthews · Head of Unit
    Involvement of clinical experts taking part in joint clinical assessments and scientific consultations under the EU Health Technology Assessment (HTA) Regulationsource ↗
  • 2025-03-26EPMETZ Tilly
    Cancer, public health researchsource ↗
  • 2025-03-06EPCHASTEL Olivier
    Politique de santé de l'Union européenne - Optimisation des traitementssource ↗
  • 2025-03-04EPJERKOVIĆ Romana
    Treatment Optimization in Oncologysource ↗

Frequently asked

How many EU lobbying meetings has European Organisation for Research and Treatment of Cancer disclosed?

European Organisation for Research and Treatment of Cancer (EU Transparency Register no. 70539554035-46) appears in 11 disclosed meetings with EU officials and MEPs between 2025-03-04 and 2026-06-03: 6 with the European Commission and 5 with Members of the European Parliament.

What does European Organisation for Research and Treatment of Cancer lobby on?

European Organisation for Research and Treatment of Cancer's disclosed EU meetings most often concern Technology. Every meeting and its topic is listed with its official source on this page.

Who does European Organisation for Research and Treatment of Cancer meet in Brussels?

Across its disclosed meetings, European Organisation for Research and Treatment of Cancer has met Commission officials including Karolina Tomaszewska-Boillot, Sandra Gallina, Patricia Reilly, and MEPs including SOKOL Tomislav, VASILE-VOICULESCU Vlad, METZ Tilly. These are counts of officially disclosed meetings, not a measure of influence.

Primary sources

Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.

Related on the graph

The same footprint, mapped onto the topics and files it touches.

Get the EU lobbying brief

We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.

See your company’s overlap with European Organisation for Research and Treatment of Cancerand the rest of the corpus.

Enter your company and Lex builds a cited Exposure Map in about 30 seconds. Free, no login.